Continuously Innovating

The development team at Celling Biosciences consists of scientists and provider alike. We are continually re-evaluating how we do things so that we are continually doing things better. We don’t just wonder if things can be done, be plant a flag in the ground and demand of ourselves that we do them.

Product Benefit Areas

Acquistion

Regenerative therapies start with a patient’s own cells, cellular components, and blood derivatives. Without state of the art rescue strategies, the foundation of regenerative therapy will never reach its potential.

Celling Biosciences has pioneered the ideas from which all modern cellular and blood derivate rescue advances have been made.

Acquistion

Regenerative therapies start with a patient’s own cells, cellular components, and blood derivatives. Without state of the art rescue strategies, the foundation of regenerative therapy will never reach its potential.

Celling Biosciences has pioneered the ideas from which all modern cellular and blood derivate rescue advances have been made.

Concentration

It’s not just a numbers game.  Concentration of cells and blood derivatives is more than just a centrifuge.  It is using a variety of different strategies to optimize the regenerative product to be delivered.  We were the first to use nano-filtration to optimize the therapeutic benefits of autologous therapies and are the only company that recognized the safety benefits of a self enclosed device to minimize infection risk.

Delivery

We don’t believe that our jobs ends when we hand the syringe to the physician.  How the autologous therapy is delivered and where it is delivered and how the therapy will be enhanced at the point of care in an homologous manner is an aspect of regenerative therapy that no other company has focused so much attention on.

Delivery

We don’t believe that our jobs ends when we hand the syringe to the physician. How the autologous therapy is delivered and where it is delivered and how the therapy will be enhanced at the point of care in an homologous manner is an aspect of regenerative therapy that no other company has focused so much attention on.

Substrates

Delivering cellular autologous therapy is as important as the the autologous component itself. Living cells require a certain environment for optimal survival and function. We have developed substrate technologies that create an environment for cells that is natural and conducive to optimal clinical outcomes. Our focus on pH and architecture ensures the best possible outcome.

Social Links

©2022 Celling Biosciences, Inc.

Site built by Two Row Studio

Log in with your credentials

or    

Forgot your details?

Create Account